Peter C. Willsher

1.6k total citations
48 papers, 1.3k citations indexed

About

Peter C. Willsher is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Peter C. Willsher has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 14 papers in Cancer Research and 13 papers in Genetics. Recurrent topics in Peter C. Willsher's work include Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer Treatment and Pharmacology (10 papers). Peter C. Willsher is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer Treatment and Pharmacology (10 papers). Peter C. Willsher collaborates with scholars based in United Kingdom, Australia and United States. Peter C. Willsher's co-authors include J.F.R. Robertson, Ian O. Ellis, Robert I. Nicholson, Julia M.W. Gee, Roger W. Blamey, Richard A. McClelland, R.W. Blamey, Sarah E. Pinder, I. H. Leach and Kwok‐Leung Cheung and has published in prestigious journals such as Cancer, Spine and British Journal of Cancer.

In The Last Decade

Peter C. Willsher

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C. Willsher United Kingdom 20 629 403 390 372 247 48 1.3k
Dong‐Young Noh South Korea 27 788 1.3× 383 1.0× 791 2.0× 342 0.9× 120 0.5× 52 1.8k
James Hackett United States 16 946 1.5× 497 1.2× 425 1.1× 297 0.8× 96 0.4× 30 1.4k
Fiona Knox United Kingdom 14 588 0.9× 415 1.0× 554 1.4× 220 0.6× 86 0.3× 26 1.2k
RW Blamey United Kingdom 17 730 1.2× 342 0.8× 769 2.0× 246 0.7× 591 2.4× 36 1.6k
Shulamith Rizel Israel 18 526 0.8× 329 0.8× 418 1.1× 273 0.7× 76 0.3× 46 1.2k
A.G.J. van der Zee Netherlands 24 528 0.8× 146 0.4× 251 0.6× 593 1.6× 301 1.2× 53 1.6k
A. Pfleiderer Germany 23 424 0.7× 215 0.5× 252 0.6× 435 1.2× 250 1.0× 105 1.5k
Isabel Chirivella Spain 16 1.1k 1.8× 200 0.5× 254 0.7× 246 0.7× 207 0.8× 53 1.5k
Furio Maggiorotto Italy 20 516 0.8× 200 0.5× 534 1.4× 225 0.6× 342 1.4× 44 1.3k
Umberto Veronesi Italy 13 345 0.5× 160 0.4× 494 1.3× 177 0.5× 198 0.8× 37 947

Countries citing papers authored by Peter C. Willsher

Since Specialization
Citations

This map shows the geographic impact of Peter C. Willsher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Willsher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Willsher more than expected).

Fields of papers citing papers by Peter C. Willsher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Willsher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Willsher. The network helps show where Peter C. Willsher may publish in the future.

Co-authorship network of co-authors of Peter C. Willsher

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Willsher. A scholar is included among the top collaborators of Peter C. Willsher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Willsher. Peter C. Willsher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chan, Arlene, Peter C. Willsher, James Anderson, et al.. (2012). Preoperative taxane‐based chemotherapy in a standardized protocol for locally advanced breast cancer. Asia-Pacific Journal of Clinical Oncology. 8(1). 62–70. 2 indexed citations
3.
4.
Willsher, Peter C.. (2007). LAPAROSCOPIC SPLENECTOMY. ANZ Journal of Surgery. 77(9). 714–715. 1 indexed citations
5.
Samnakay, Naeem, et al.. (2005). Rates for mastectomy are lower in women attending a breast‐screening programme. ANZ Journal of Surgery. 75(11). 936–939. 12 indexed citations
6.
Kenny, F.S., Peter C. Willsher, Julia M.W. Gee, et al.. (2001). Change in Expression of ER, bcl-2 and MIB1 on Primary Tamoxifen and Relation to Response in ER Positive Breast Cancer. Breast Cancer Research and Treatment. 65(2). 135–144. 32 indexed citations
7.
Willsher, Peter C., S Pinder, Julia M.W. Gee, et al.. (1999). C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer.. PubMed. 18(5B). 3695–8. 25 indexed citations
8.
Willsher, Peter C., et al.. (1999). Early laparoscopic cholecystectomy for acute cholecystitis: a safe procedure. Journal of Gastrointestinal Surgery. 3(1). 50–53. 43 indexed citations
9.
Robertson, J.F.R., Peter C. Willsher, L. Winterbottom, R.W. Blamey, & S.M. Thorpe. (1999). Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer. European Journal of Cancer. 35(2). 214–218. 75 indexed citations
10.
Gee, Julia M.W., et al.. (1998). Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy. British Journal of Cancer. 77(10). 1653–1656. 17 indexed citations
11.
Robertson, J.F.R., et al.. (1997). The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer. European Journal of Cancer. 33(11). 1774–1779. 58 indexed citations
12.
Willsher, Peter C., et al.. (1997). Audit of a conservative management policy of the axilla in elderly patients with operable breast cancer. European Journal of Surgical Oncology. 23(4). 339–340. 17 indexed citations
13.
Willsher, Peter C., et al.. (1997). A comparison outcome of male breast cancer with female breast cancer. The American Journal of Surgery. 173(3). 185–188. 90 indexed citations
14.
Willsher, Peter C., I. H. Leach, Ian O. Ellis, et al.. (1997). Male breast cancer: pathological and immunohistochemical features.. PubMed. 17(3C). 2335–8. 70 indexed citations
15.
Willsher, Peter C., et al.. (1996). Prognostic significance of serum c-erbB-2 protein in breast cancer patients. Breast Cancer Research and Treatment. 40(3). 251–255. 63 indexed citations
16.
Poole, Garth, Peter C. Willsher, Sarah E. Pinder, et al.. (1996). DIAGNOSIS OF BREAST CANCER WITH CORE‐BIOPSY AND FINE NEEDLE ASPIRATION CYTOLOGY. Australian and New Zealand Journal of Surgery. 66(9). 592–594. 25 indexed citations
17.
Gee, Julia M.W., Ian O. Ellis, J.F.R. Robertson, et al.. (1995). Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. International Journal of Cancer. 64(4). 269–273. 180 indexed citations
18.
Gee, Julia M.W., J.F.R. Robertson, Ian O. Ellis, et al.. (1994). Immunocytochemical localization of BCL‐2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. International Journal of Cancer. 59(5). 619–628. 147 indexed citations
19.
Willsher, Peter C., et al.. (1993). Mucin 1 antigens in the serum and bronchial lavage fluid of patients with lung cancer. Cancer. 72(10). 2936–2942. 12 indexed citations
20.
Willsher, Peter C. & Richard Cade. (1991). TRAUMATIC DIAPHRAGMATIC RUPTURE. Australian and New Zealand Journal of Surgery. 61(3). 207–210. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dong‐Young Noh Breakdown of academic impact, for papers by James Hackett Breakdown of academic impact, for papers by Fiona Knox Breakdown of academic impact, for papers by RW Blamey Breakdown of academic impact, for papers by Shulamith Rizel Breakdown of academic impact, for papers by A.G.J. van der Zee Breakdown of academic impact, for papers by A. Pfleiderer Breakdown of academic impact, for papers by Isabel Chirivella Breakdown of academic impact, for papers by Furio Maggiorotto Breakdown of academic impact, for papers by Umberto Veronesi
Rankless by CCL
2026